Mae Dechristy

NPI: 1609374479
Total Payments
$9,924
2024 Payments
$4,147
Companies
15
Transactions
52
Medicare Patients
506
Medicare Billing
$130,275

Payment Breakdown by Category

Consulting$3,338 (33.6%)
Other$2,275 (22.9%)
Travel$2,183 (22.0%)
Food & Beverage$1,948 (19.6%)
Education$180.24 (1.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $3,338 4 33.6%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,275 4 22.9%
Travel and Lodging $2,183 4 22.0%
Food and Beverage $1,948 37 19.6%
Education $180.24 3 1.8%

Top Paying Companies

Company Total Records Latest Year
Genmab U.S., Inc. $7,881 14 $0 (2024)
E.R. Squibb & Sons, L.L.C. $412.46 6 $0 (2024)
Seagen Inc. $256.30 3 $0 (2023)
PFIZER INC. $225.00 1 $0 (2024)
Novocure Inc. $157.47 2 $0 (2024)
AstraZeneca Pharmaceuticals LP $145.93 4 $0 (2024)
Merck Sharp & Dohme LLC $143.96 3 $0 (2024)
JAZZ PHARMACEUTICALS INC. $139.29 1 $0 (2024)
Daiichi Sankyo Inc. $134.21 4 $0 (2024)
Astellas Pharma US Inc $112.88 4 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $4,147 23 Genmab U.S., Inc. ($3,110)
2023 $5,284 24 Genmab U.S., Inc. ($4,770)
2022 $235.16 2 E.R. Squibb & Sons, L.L.C. ($119.32)
2021 $257.82 3 AstraZeneca Pharmaceuticals LP ($97.85)

All Payment Transactions

52 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
12/18/2024 Gilead Sciences, Inc. Trodelvy (Drug) Food and Beverage In-kind items and services $109.25 General
Category: ONC
11/22/2024 Regeneron Healthcare Solutions, Inc. LIBTAYO (Biological) Food and Beverage In-kind items and services $16.98 General
Category: ONCOLOGY
11/15/2024 AstraZeneca Pharmaceuticals LP LYNPARZA (Drug) Food and Beverage In-kind items and services $16.64 General
Category: Oncology
10/18/2024 AstraZeneca Pharmaceuticals LP ENHERTU (Biological) Food and Beverage In-kind items and services $16.15 General
Category: Oncology
10/18/2024 E.R. Squibb & Sons, L.L.C. KRAZATI (Drug) Food and Beverage Cash or cash equivalent $14.07 General
Category: Oncology
10/16/2024 Regeneron Healthcare Solutions, Inc. LIBTAYO (Biological) Food and Beverage In-kind items and services $15.93 General
Category: ONCOLOGY
08/03/2024 Novocure Inc. Optune (Device) Food and Beverage Cash or cash equivalent $23.10 General
Category: Oncology
07/15/2024 Genmab U.S., Inc. Tivdak (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,000.00 General
Category: Oncology
05/24/2024 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $15.00 General
Category: ONCOLOGY
05/23/2024 Daiichi Sankyo Inc. Enhertu (Drug) Education In-kind items and services $99.99 General
Category: ONCOLOGY
05/17/2024 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $12.65 General
Category: ONCOLOGY
05/15/2024 Astellas Pharma US Inc Padcev (Drug) Food and Beverage In-kind items and services $13.60 General
Category: Oncology
05/10/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological), LYNPARZA Food and Beverage In-kind items and services $14.72 General
Category: ONCOLOGY
05/07/2024 Genmab U.S., Inc. Tivdak (Drug) Food and Beverage In-kind items and services $123.46 General
Category: Oncology
05/03/2024 Genmab U.S., Inc. Tivdak (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $900.00 General
Category: Oncology
05/01/2024 Genmab U.S., Inc. Tivdak (Drug) Travel and Lodging In-kind items and services $1,086.99 General
Category: Oncology
04/25/2024 PFIZER INC. TIVDAK (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $225.00 General
Category: Oncology
04/24/2024 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $124.99 General
Category: Oncology
04/18/2024 E.R. Squibb & Sons, L.L.C. AUGTYRO (Drug) Food and Beverage Cash or cash equivalent $15.44 General
Category: Oncology
04/17/2024 Myriad Genetic Laboratories, Inc. MYRISK (Device) Food and Beverage In-kind items and services $22.75 General
Category: ONCOLOGY
03/01/2024 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $6.57 General
Category: ONCOLOGY
02/16/2024 JAZZ PHARMACEUTICALS INC. ZEPZELCA (Drug) Food and Beverage In-kind items and services $139.29 General
Category: HEMATOLOGY/ONCOLOGY
01/04/2024 Novocure Inc. Optune (Device) Food and Beverage Cash or cash equivalent $134.37 General
Category: Oncology
11/16/2023 Celgene Corporation REBLOZYL (Biological) Food and Beverage Cash or cash equivalent $14.81 General
Category: Hematology
11/15/2023 Genmab U.S., Inc. Tivdak (Drug) Food and Beverage In-kind items and services $115.00 General
Category: Oncology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 131 374 $117,290 $34,066
2022 3 135 406 $114,883 $39,090
2021 3 143 424 $112,940 $39,251
2020 3 97 241 $61,530 $17,868
Total Patients
506
Total Services
1,445
Medicare Billing
$130,275
Procedure Codes
12

All Medicare Procedures & Services

12 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 90 313 $95,493 $27,530 28.8%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 28 44 $17,841 $5,547 31.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 13 17 $3,956 $988.95 25.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 76 313 $85,885 $28,876 33.6%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 37 62 $21,965 $8,189 37.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 22 31 $7,033 $2,025 28.8%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 77 327 $87,480 $30,555 34.9%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 43 65 $14,355 $4,366 30.4%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 23 32 $11,105 $4,330 39.0%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 56 186 $49,055 $14,808 30.2%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 26 36 $7,833 $2,008 25.6%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2020 15 19 $4,642 $1,053 22.7%

About Mae Dechristy

Mae Dechristy is a Family healthcare provider based in Sewell, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2018. The National Provider Identifier (NPI) number assigned to this provider is 1609374479.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mae Dechristy has received a total of $9,924 in payments from pharmaceutical and medical device companies, with $4,147 received in 2024. These payments were reported across 52 transactions from 15 companies. The most common payment nature is "Consulting Fee" ($3,338).

As a Medicare-enrolled provider, Dechristy has provided services to 506 Medicare beneficiaries, totaling 1,445 services with total Medicare billing of $130,275. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.

Practice Information

  • Specialty Family
  • Location Sewell, NJ
  • Active Since 01/26/2018
  • Last Updated 01/26/2018
  • Taxonomy Code 363LF0000X
  • Entity Type Individual
  • NPI Number 1609374479

Products in Payments

  • Tivdak (Drug) $7,881
  • OPDIVO (Biological) $382.95
  • TIVDAK (Biological) $375.00
  • Optune (Device) $157.47
  • KEYTRUDA (Biological) $143.96
  • ZEPZELCA (Drug) $139.29
  • Enhertu (Drug) $134.21
  • Trodelvy (Drug) $109.25
  • TAGRISSO (Drug) $97.85
  • PADCEV (Biological) $94.97
  • MYRISK (Device) $94.40
  • LIBTAYO (Biological) $32.91
  • LUMAKRAS (Drug) $31.80
  • REBLOZYL (Biological) $31.78
  • ENHERTU (Biological) $31.44
  • Padcev (Drug) $29.73
  • Xtandi (Drug) $18.15
  • LYNPARZA (Drug) $16.64
  • AUGTYRO (Drug) $15.44
  • KRAZATI (Drug) $14.07

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Doctors in Sewell